The present invention relates to the field of immunology, specifically the branch of adjuvants and vaccines. The technical objective is to obtain adjuvants based on cochlear structures that are neither proteolipidic nor lipidic and that contain microbe-associated molecular patterns (MAMPs) and have the optional addition of antibiotics/chemotherapeutic agents with the aim of using them as vaccine adjuvants for the treatment and prevention of veterinary and human diseases. Additionally, these would be used as immunopotentiators in veterinary and human formulations. It is also a technical objective of this patent to utilize the said new cochlear structures with particular antigens added or liberated in vivo for the combined effect of immunopotentiation and antibiotics/chemotherapeutic agents in infectious diseases to obtain therapeutic vaccines for veterinary and human use in the pharmaceutical industry. The invention also relates to the method for obtaining sterile cochlear structures.
本发明涉及免疫学领域,特别是佐剂和疫苗分支。其技术目标是获得基于耳蜗结构的佐剂,这种佐剂既不是蛋白脂质的,也不是脂质的,含有微
生物相关分子模式(M
AMPs),并可选择添加抗生素/化疗药物,目的是将其用作治疗和预防兽医和人类疾病的疫苗佐剂。此外,它们还可用作兽医和人类配方中的免疫
促进剂。本专利的另一个技术目标是利用上述新的耳蜗结构,在体内添加或释放特定抗原,在传染病中发挥免疫增强剂和抗生素/化疗药物的联合作用,以获得用于制药业的兽用和人用治疗疫苗。本发明还涉及获得无菌耳蜗结构的方法。